The U.S. Food and Drug Administration has recorded an Abbreviated New Drug Application (ANDA) identified as ANDA070169 for a Tolazamide product. The product is an oral tablet containing 500 mg of Tolazamide, assigned product number 001. The sponsor listed is USL Pharma. The filing indicates that the product is not a reference drug, does not use a reference standard, and its marketing status is currently marked as discontinued.
法规动态2026年9月17日•3 分钟阅读
FDA Lists Tolazamide 500 mg Oral Tablet (ANDA070169) – Discontinued
The FDA’s ANDA070169 filing for Tolazamide 500 mg oral tablets by USL Pharma is marked as discontinued.
由 Pharmacountry 团队整理 · 来源： FDA.gov
主题：
评分
(0)
(0)
(0)
(0)
(0)
留下您的评分